La molécula que combate la obesidad y ahora promete revolucionar el tratamiento de la apnea del sueño – ELTIEMPO.COM

Recent clinical trials have identified that tirzepatide, a dual-action molecule primarily used for weight management and type 2 diabetes, significantly reduces the severity of obstructive sleep apnea (OSA) in adults with obesity. Published findings in the New England Journal of Medicine indicate that participants treated with the medication experienced a substantial decrease in the number … Read more

Foods That Accelerate Fatty Liver Damage: Common Foods You’re Likely Eating Daily

As a physician practicing in Berlin, I often see patients who are surprised to learn that their metabolic health is being silently impacted by choices they make in the supermarket aisle. The term “fatty liver disease”—specifically metabolic dysfunction-associated steatotic liver disease (MASLD)—is increasingly common, yet many people remain unaware that the condition is often driven … Read more